177 related articles for article (PubMed ID: 26917230)
1. A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.
Chen L; Engel BE; Welsh EA; Yoder SJ; Brantley SG; Chen DT; Beg AA; Cao C; Kaye FJ; Haura EB; Schabath MB; Cress WD
J Thorac Oncol; 2016 Jun; 11(6):838-49. PubMed ID: 26917230
[TBL] [Abstract][Full Text] [Related]
2. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer.
Zheng J; Deng Y; Huang B; Chen X
Front Immunol; 2024; 15():1387896. PubMed ID: 38736875
[TBL] [Abstract][Full Text] [Related]
4. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence.
Mitchell KG; Parra ER; Zhang J; Nelson DB; Corsini EM; Villalobos P; Moran CA; Skoulidis F; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
Ann Thorac Surg; 2020 Oct; 110(4):1131-1138. PubMed ID: 32442617
[TBL] [Abstract][Full Text] [Related]
5. Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
J Thorac Oncol; 2015 Mar; 10(3):531-4. PubMed ID: 25695224
[TBL] [Abstract][Full Text] [Related]
6. STK11 mutation impacts CD1E expression to regulate the differentiation of macrophages in lung adenocarcinoma.
Zhang Q; Feng J; Liu K; Yang X; Huang Y; Tang B
Immun Inflamm Dis; 2023 Jul; 11(7):e958. PubMed ID: 37506141
[TBL] [Abstract][Full Text] [Related]
7. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract][Full Text] [Related]
8. Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma.
Li Z; Ding B; Xu J; Mao K; Zhang P; Xue Q
Front Oncol; 2020; 10():580027. PubMed ID: 33425731
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
10. Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.
Pécuchet N; Laurent-Puig P; Mansuet-Lupo A; Legras A; Alifano M; Pallier K; Didelot A; Gibault L; Danel C; Just PA; Riquet M; Le Pimpec-Barthes F; Damotte D; Fabre E; Blons H
Oncotarget; 2017 Apr; 8(14):23831-23840. PubMed ID: 26625312
[TBL] [Abstract][Full Text] [Related]
11.
Papillon-Cavanagh S; Doshi P; Dobrin R; Szustakowski J; Walsh AM
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32312757
[TBL] [Abstract][Full Text] [Related]
12. A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma.
Kaufman JM; Yamada T; Park K; Timmers CD; Amann JM; Carbone DP
Cancer Res; 2017 Jan; 77(1):153-163. PubMed ID: 27821489
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and Selective Anticancer Efficacy of
Park C; Lee Y; Je S; Chang S; Kim N; Jeong E; Yoon S
Mol Cells; 2019 Nov; 42(11):804-809. PubMed ID: 31697874
[TBL] [Abstract][Full Text] [Related]
14. Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
Kim HR; Cho BC; Shim HS; Lim SM; Kim SK; Chang J; Kim DJ; Kim JH
Lung Cancer; 2014 Mar; 83(3):374-82. PubMed ID: 24468202
[TBL] [Abstract][Full Text] [Related]
15. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
Chen M; Liu B; Xiao J; Yang Y; Zhang Y
Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
[TBL] [Abstract][Full Text] [Related]
16.
Pons-Tostivint E; Lugat A; Fontenau JF; Denis MG; Bennouna J
Cells; 2021 Nov; 10(11):. PubMed ID: 34831355
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome.
Mehenni H; Resta N; Guanti G; Mota-Vieira L; Lerner A; Peyman M; Chong KA; Aissa L; Ince A; Cosme A; Costanza MC; Rossier C; Radhakrishna U; Burt RW; Picard D
Dig Dis Sci; 2007 Aug; 52(8):1924-33. PubMed ID: 17404884
[TBL] [Abstract][Full Text] [Related]
18. Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
Donnelly LL; Hogan TC; Lenahan SM; Nandagopal G; Eaton JG; Lebeau MA; McCann CL; Sarausky HM; Hampel KJ; Armstrong JD; Cameron MP; Sidiropoulos N; Deming P; Seward DJ
Carcinogenesis; 2021 Dec; 42(12):1428-1438. PubMed ID: 34849607
[TBL] [Abstract][Full Text] [Related]
19. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
Su GH; Hruban RH; Bansal RK; Bova GS; Tang DJ; Shekher MC; Westerman AM; Entius MM; Goggins M; Yeo CJ; Kern SE
Am J Pathol; 1999 Jun; 154(6):1835-40. PubMed ID: 10362809
[TBL] [Abstract][Full Text] [Related]
20. STK11 mutation affects the killing effect of NK cells to promote the progression of lung adenocarcinoma.
Huang Y; Zhang H; Feng J; Tang B
APMIS; 2022 Nov; 130(11):647-656. PubMed ID: 35988018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
